Circulating and Hepatic BDCA1+, BDCA2+, and BDCA3+ Dendritic Cells Are Differentially Subverted in Patients With Chronic HBV Infection.

MLA

Ouaguia, Laurissa, et al. “Circulating and Hepatic BDCA1+, BDCA2+, and BDCA3+ Dendritic Cells Are Differentially Subverted in Patients With Chronic HBV Infection.” Frontiers in Immunology, vol. 10, Feb. 2019, p. 112. EBSCOhost, https://doi.org/10.3389/fimmu.2019.00112.

APA

Ouaguia, L., Leroy, V., Dufeu-Duchesne, T., Durantel, D., Decaens, T., Hubert, M., Valladeau-Guilemond, J., Bendriss-Vermare, N., Chaperot, L., & Aspord, C. (2019). Circulating and Hepatic BDCA1+, BDCA2+, and BDCA3+ Dendritic Cells Are Differentially Subverted in Patients With Chronic HBV Infection. Frontiers in Immunology, 10, 112. https://doi.org/10.3389/fimmu.2019.00112

Chicago

Ouaguia, Laurissa, Vincent Leroy, Tania Dufeu-Duchesne, David Durantel, Thomas Decaens, Margaux Hubert, Jenny Valladeau-Guilemond, Nathalie Bendriss-Vermare, Laurence Chaperot, and Caroline Aspord. 2019. “Circulating and Hepatic BDCA1+, BDCA2+, and BDCA3+ Dendritic Cells Are Differentially Subverted in Patients With Chronic HBV Infection.” Frontiers in Immunology 10 (February): 112. doi:10.3389/fimmu.2019.00112.